世界の免疫抑制薬市場予測2019-2028

◆英語タイトル:GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET FORECAST 2019-2028
◆商品コード:INK20AG036
◆発行会社(リサーチ会社):Inkwood Research
◆発行日:2020年1月
◆ページ数:135
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥260,000見積依頼/購入/質問フォーム
Multi LicenseUSD3,000 ⇒換算¥312,000見積依頼/購入/質問フォーム
Enterprisewide PriceUSD4,500 ⇒換算¥468,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はInkwood Research社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Inkwood Research社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査レポートでは、免疫抑制薬の世界市場について調査を行い、調査手法、エグゼクティブサマリー、市場動向、主要分析、流通チャネル別(病院薬局、小売薬局、オンライン薬局)分析、エンドユーザー別分析、薬剤クラス別分析、地域別分析、企業情報などをまとめております。
・調査手法
・エグゼクティブサマリー
・市場動向
・主要分析
・免疫抑制薬の世界市場規模:流通チャネル別(病院薬局、小売薬局、オンライン薬局)
・免疫抑制薬の世界市場規模:エンドユーザー別
・免疫抑制薬の世界市場規模:薬剤クラス別
・免疫抑制薬の世界市場規模:地域別
・企業情報
【レポートの概要】

KEY FINDINGS
The global immunosuppressant drugs market is projected to register growth at a CAGR of 4.17% during the projected period, 2019-2028. The growing incidences of autoimmune disorders, the growing pharmaceutical industry, and the increase in organ transplantation, are the major factors fueling the market growth.

MARKET INSIGHTS
Organ transplantation has been on the rise across the globe. This is because of the prevalence of genetic conditions like cystic fibrosis, heart defect, and polycystic kidney disease. Infections like hepatitis, damage to organs due to chronic conditions like diabetes, physical injuries, are other factors that are responsible for an organ transplant. Immunosuppressive drugs come into the scene post organ transplantation, while combatting the hyper-immune response of the patient’s immune system. Thus, the growing demand for organ transplantation procedures is estimated to have a major impact on the growth of the market. Though immunosuppressive drugs have improved the outcome of organ transplantation, the side effects of such drugs can be serious, and this is one of the major factors hindering the market growth.

REGIONAL INSIGHTS
The global immunosuppressant drugs market is geographically analyzed through the regions of Europe, North America, Asia Pacific, and the rest of the world. The North America region garnered the largest market share, while the Asia Pacific region is slated to record the highest growth rate by the end of the forecast period. The government funding, prevailing auto-immune diseases, and increasing demands for organ transplantation, contribute to the market prospects of North America.

COMPETITIVE INSIGHTS
The competitive environment of the market is evaluated to be stiff, given the workings of the pharmaceutical business. Some of the leading companies in the market are Allergan Plc (Acquired By AbbVie Inc), Bristol-Myers Squibb Company, Cipla Ltd, AbbVie Inc, Astellas Pharma Inc, etc.

Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter’s Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

【レポートの目次】

TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW
3. MARKET DYNAMICS
3.1. DEVELOPMENT OF IMMUNOSUPPRESSANT DRUGS
3.2. MARKET DEFINITION
3.3. KEY DRIVERS
3.3.1. INCREASE IN THE NUMBER OF AUTOIMMUNE DISORDERS
3.3.2. RISE IN ORGAN TRANSPLANTATION
3.3.3. GROWTH IN THE PHARMACEUTICAL INDUSTRY
3.4. KEY RESTRAINTS
3.4.1. SIDE EFFECTS OF IMMUNOSUPPRESSANT DRUGS
3.4.2. LACK OF AWARENESS ABOUT ORGAN DONATION
4. KEY ANALYTICS
4.1. KEY INVESTMENT INSIGHTS
4.2. PORTER’S FIVE FORCE ANALYSIS
4.2.1. BUYER POWER
4.2.2. SUPPLIER POWER
4.2.3. SUBSTITUTION
4.2.4. NEW ENTRANTS
4.2.5. INDUSTRY RIVALRY
4.3. OPPORTUNITY MATRIX
4.4. VENDOR LANDSCAPE
5. MARKET BY DISTRIBUTION CHANNEL
5.1. HOSPITAL PHARMACIES
5.2. RETAIL PHARMACIES
5.3. ONLINE PHARMACIES
6. MARKET BY END-USER
6.1. ORGAN TRANSPLANTATION
6.2. AUTOIMMUNE DISORDERS
6.3. OTHERS
7. MARKET BY DRUG CLASS
7.1. CORTICOSTEROIDS
7.2. MONOCLONAL ANTIBODIES
7.3. CALCINEURIN INHIBITORS
7.4. MTOR INHIBITORS
7.5. OTHERS
8. GEOGRAPHICAL ANALYSIS
8.1. NORTH AMERICA
8.1.1. UNITED STATES
8.1.2. CANADA
8.2. EUROPE
8.2.1. UNITED KINGDOM
8.2.2. GERMANY
8.2.3. FRANCE
8.2.4. ITALY
8.2.5. RUSSIA
8.2.6. BELGIUM
8.2.7. POLAND
8.2.8. REST OF EUROPE
8.3. ASIA PACIFIC
8.3.1. CHINA
8.3.2. JAPAN
8.3.3. INDIA
8.3.4. SOUTH KOREA
8.3.5. INDONESIA
8.3.6. THAILAND
8.3.7. VIETNAM
8.3.8. AUSTRALIA & NEW ZEALAND
8.3.9. REST OF ASIA PACIFIC
8.4. REST OF WORLD
8.4.1. LATIN AMERICA
8.4.2. MIDDLE EAST & AFRICA
9. COMPANY PROFILES
9.1. ABBVIE INC
9.2. ALLERGAN PLC (ACQUIRED BY ABVIE INC)
9.3. ASTELLAS PHARMA INC
9.4. BRISTOL-MYERS SQUIBB COMPANY
9.5. CIPLA LTD
9.6. DR. REDDY’S LABORATORIES LTD
9.7. F HOFFMANN-LA ROCHE AG
9.8. GLAXOSMITHKLINE PLC
9.9. INTAS PHARMACEUTICALS LTD (ACCORD HEALTHCARE LTD)
9.10. JANSSEN PHARMACEUTICALS NV (JHONSON & JHONSON)
9.11. MYLAN NV
9.12. NOVARTIS INTERNATIONAL AG (SANDOZ)
9.13. PFIZER INC
9.14. SANOFI SA
9.15. VELOXIS PHARMACEUTICALS

LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - IMMUNOSUPPRESSANT DRUGS
TABLE 2: SIDE EFFECTS OF IMMUNOSUPPRESSANT DRUGS
TABLE 3: TOP 15 POSITIVE NET EXPORTS COUNTRIES AND NEGATIVE NET EXPORTS FOR DRUGS & MEDICINES COUNTRIES
TABLE 4: GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET, BY DISTRIBUTION CHANNEL, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 5: GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET, BY DISTRIBUTION CHANNEL, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 6: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 7: GLOBAL HOSPITAL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 8: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 9: GLOBAL RETAIL PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 10: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 11: GLOBAL ONLINE PHARMACIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 12: GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET, BY END-USER, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 13: GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET, BY END-USER, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 14: GLOBAL ORGAN TRANSPLANTATION MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 15: GLOBAL ORGAN TRANSPLANTATION MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 16: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 17: GLOBAL AUTOIMMUNE DISORDERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 18: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 19: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 20: GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET, BY CLASS, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 21: GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET, BY CLASS, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 22: GLOBAL CORTICOSTEROIDS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 23: GLOBAL CORTICOSTEROIDS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 24: GLOBAL MONOCLONAL ANTIBODIES MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 25: GLOBAL MONOCLONAL ANTIBODIES MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 26: GLOBAL CALCINEURIN INHIBITORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 27: GLOBAL CALCINEURIN INHIBITORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 28: GLOBAL MTOR INHIBITORS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 29: GLOBAL MTOR INHIBITORS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 30: GLOBAL OTHERS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 31: GLOBAL OTHERS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 32: GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET, BY GEOGRAPHY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 33: GLOBAL IMMUNOSUPPRESSANT DRUGS MARKET, BY GEOGRAPHY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 34: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 35: NORTH AMERICA IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 36: EUROPE IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 37: EUROPE IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 38: ASIA PACIFIC IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 39: ASIA PACIFIC IMMUNOSUPPRESSANT DRUGS MARKET, BY COUNTRY, FORECAST YEARS, 2019-2028 (IN $ MILLION)
TABLE 40: REST OF WORLD IMMUNOSUPPRESSANT DRUGS MARKET, BY REGION, HISTORICAL YEARS, 2016-2019 (IN $ MILLION)
TABLE 41: REST OF WORLD IMMUNOSUPPRESSANT DRUGS MARKET, BY REGION, FORECAST YEARS, 2019-2028 (IN $ MILLION)


【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[世界の免疫抑制薬市場予測2019-2028]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆